[Strengthening the clinical research of minimally invasive glaucoma surgery]

Glaucoma is a leading cause of irreversible blindness in the world. The reduction of intraocular pressure is the main clinical treatment. Due to the limitations of traditional filter surgery, a variety of minimally invasive glaucoma surgery (MIGS) procedures have been applied in clinical practice in recent years. Quite a few of them have been carried out in China and achieved good results. At the same time, domestic technology enterprises are actively engaged in the development, innovation and localization of the MIGS equipment. However, there are still some problems in MIGS in China, which need to be paid attention to and require corresponding clinical research, so as to make it a new highlight in the clinical diagnosis and treatment of glaucoma.青光眼为全球首位不可逆致盲眼病，降低眼压是其主要治疗手段。由于传统滤过性手术存在诸多问题，近年多种微小切口青光眼手术（MIGS）进入我国临床并取得良好疗效，国内科技企业也在进行MIGS装置和器械国产化。本文在指出目前我国开展MIGS存在须严格掌握手术适应证、临床研究规模和质量不足、手术装置和器械价格昂贵、国内疗效不同于国外报道等问题的基础上，提出重视并开展MIGS临床研究的必要性及方法，以期指导临床多方面大量开展高质量相关研究，使MIGS能造福于我国广大青光眼患者。.